GJWM
GILD icon

Gilliland Jeter Wealth Management’s Gilead Sciences GILD Stock Holding History

Gilliland Jeter Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,009
Closed -$84.6K – 360
2024
Q3 		$84.6K Buy
1,009
+9
+0.9% +$687 0.03% 242
2024
Q2 		$68.6K Buy
+1,000
New +$66.7K 0.02% 254

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gilliland Jeter Wealth Management's GILD Position: Q4 2024 in Review

Gilliland Jeter Wealth Management sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 1,009 shares — an estimated $84.6K sold.

Gilliland Jeter Wealth Management first reported a position in GILD in Q2 2024 and held it in 2 quarters. The position peaked at $84.6K in Q3 2024. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Gilliland Jeter Wealth Management reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Gilliland Jeter Wealth Management sold 1,009 Gilead Sciences shares in Q4 2024, an estimated $84.6K.
  • Gilliland Jeter Wealth Management first reported a position in Gilead Sciences in Q2 2024 and held it in 2 quarters.
  • Gilliland Jeter Wealth Management's Gilead Sciences position peaked at $84.6K in Q3 2024.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Gilliland Jeter Wealth Management's 13F filing for Q4 2024, filed 28 Jan 2025.